Dividend / buyback / bonusMajor developmentFiled on BSE ·

Neogen Chemicals Limited reports FY 2025-26 results, NCD listing, and key events

Neogen Chemicals · Chemicals & Petrochemicals

Arthneeti Research DeskPublished 1 min read
₹200 CrDividend / buyback / bonus

Key highlights

  • Posted consolidated audited financial results approved May 16, 2026, with unmodified audit opinion; includes subsidiaries and joint venture.
  • Listed ₹200 crore 10.50% secured non-convertible debentures on BSE from August 14, 2025; security cover ratio 2.26 as of March 31, 2026.
  • Approved preferential allotment of 10,00,000 equity shares at ₹1,610/share to Cadamba Solutions Private Limited; allotment done April 18, 2026.

Why it's rated major development: the year-on-year change is 182% (50% or more)

Figures checked against the filing by a second AI read. About the business, not the share price.

Original filing

Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015

Read the filing on BSE (PDF) →

Companies guiding to strong growth

Ranked by management's own guidance on revenue and margins — not by us.

Rossell Techsys

Aerospace & Defense

Revenue growth 40%+Margin up 2%+

Sign up free to see all 6 →

See full rankings

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

More from Neogen Chemicals

Other dividend / buyback / bonus filings this fortnight

All dividend / buyback / bonus filings →

Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.